510(k) Report

510(k) · Cleared

Recalled · Class II · 2022

Vitros Immunodiagnostics Products LH Reagent Pack (Gem.1055) and LH Calibrators (Gem.CO55)

K964982510(k) TraditionalCleared Feb 20, 199770-day reviewClass I21 CFR 862.1485Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Johnson & Johnson Clinical Diagnostics, Inc. · CEP Radioimmunoassay, Luteinizing Hormone

Cleared on Feb 20, 1997 after a 70-day review. FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known. It has been recalled once.

Decided
Feb 20, 1997
Review
70 days
Class
Class I
Product code
CEP
Recalls
1
Predicates
0

FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known.

FIG. 1 — Lineage of K964982Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CEP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against?

FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Mar 25, 2022Class IIZ-1113-2022Device DesignFalsely high or delayed patient and QC results may occur due to low end imprecision. VITROS Immunodiagnostic Products FSH, LH and Prol Reagents Low End Imprecision. Low-level quality control (QC) and patient samples at the low end of the…

No ancestor or descendant has a Class I recall.

How does its category compare?

All CEP devices

CEP Radioimmunoassay, Luteinizing Hormone: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CEP

FDA has decided no CEP device since 2007.

Median 510(k) review, days · CEP

Too few CEP 510(k)s in any year since 2007 to give a median.

Recalls per year · CEP

1in 2022

2012: 12021: 12022: 1
2007high 1 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CEP

1in 2023

2007: 52008: 22011: 32014: 172015: 12023: 1
2007high 17 (2014) · low 0 (2009)2025

MAUDE reports naming product code CEP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—05
20080—02
20090—00
20100—00
20110—03
20120—10
20130—00
20140—017
20150—01
20160—00
20170—00
20180—00
20190—00
20200—00
20210—10
20220—10
20230—01
20240—00
20250—00
20260—0—
Cite this page

510(k) Report. “K964982: Vitros Immunodiagnostics Products LH Reagent Pack (Gem.1055) and LH Calibrators (Gem.CO55).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K964982

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026